GB/T 43584.2-2023
ActiveBiotechnology—Massively parallel sequencing—Part 2: Quality evaluation of sequencing data
生物技术 大规模并行测序 第2部分：测序数据的质量评估
Application Summary AI generated
This standard specifies methods and metrics for evaluating the quality of sequencing data generated by massively parallel sequencing platforms. It is applied in biotechnology and clinical testing contexts, such as genomic research, diagnostic laboratories, and bioinformatics pipelines, to ensure data reliability before downstream analysis. The standard is used by sequencing service providers, research institutions, and regulatory bodies to benchmark data accuracy, completeness, and error rates.
Related Standards
NY/T 702-2003
Hop
NY/T 629-2002
Propolis
NY 624-2002
Jun Mu No. 1 white pig
NY 626-2002
Shennong synthetic line pig
NY 625-2002
Composite line DEKALB breeding pig
NY 623-2002
Inner Mongolia Cashmere Goat
GB/Z 44313-2024
Biotechnology—Biobanking—Requirements for the biobanking of plant biological material for research and development
GB/Z 44314-2024
Biotechnology—Biobanking—Requirements for the biobanking of animal biological material
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.